Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Enxhi Lalo"'
Autor:
Mahesh Swaminathan, Mai M. Aly, Abdul Moiz Khan, Bayan Al Share, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Katherine G. Akers, Seongho Kim, Suresh Balasubramanian
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 165-173 (2023)
Abstract Several FLT3 inhibitors(i) are available to treat relapsed/refractory (R/R) FLT3‐internal tandem duplicated acute myeloid leukemia (AML). This study analyzes the efficacies of various FLT3i (types 1 and 2) tested in clinical trials in trea
Externí odkaz:
https://doaj.org/article/b7c23a0461fe4c168747b376b89b966f
Autor:
Mahesh Swaminathan, Mai M. Aly, Abdul Moiz Khan, Bayan Al Share, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Katherine G. Akers, Seongho Kim, Suresh Balasubramanian
Publikováno v:
eJHaem. 4:165-173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31244343a9d29ae660cd9dbf83c70406
https://doi.org/10.1002/jha2.616
https://doi.org/10.1002/jha2.616
Autor:
Vikram Dhillon, Abdul Moiz Khan, Ali Al Sbihi, Sushmitha Nanja Reddy, Enxhi Lalo, Harry Ramos, Jay Yang, Anupama Kottam, Suresh Kumar Balasubramanian
Publikováno v:
Blood. 140:6183-6184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c678ad4042f88eac796e8f493007499
https://doi.org/10.1182/blood-2022-169932
https://doi.org/10.1182/blood-2022-169932
Autor:
Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian
Publikováno v:
Blood. 140:6189-6190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d06621da19a220e34248dc76ef5b9d91
https://doi.org/10.1182/blood-2022-171131
https://doi.org/10.1182/blood-2022-171131
Autor:
Stephanie J. Blocker, Anthony F. Shields, Helen Lee, Lisa Polin, Kirk A. Douglas, Bart S. Hendriks, Wei Chen, Enxhi Lalo
Publikováno v:
Theranostics
Liposomes (LP) deliver drug to tumors due to enhanced permeability and retention (EPR). LP were labeled with 64Cu for positron emission tomography (PET) to image tumor localization. Bevacizumab (bev), a VEGF targeted antibody, may modify LP delivery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8611a6a1653d681e0d237828c69b6b60
http://europepmc.org/articles/PMC5695009
http://europepmc.org/articles/PMC5695009